[1]
“Assessing the efficacy of various treatment regimens for patients with endocrine ophthalmopathy associated with Graves’ disease”, Ukr. j. ophthalmol. , no. 1, pp. 51–57, Aug. 2025, doi: 10.31288/oftalmolzh202215157.